What is CHMMF stock price today?

Visit our real-time dashboard for the current CHMMF stock price and live market data.

Is CHMMF stock going up or down today?

CHMMF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CHMMF stock now?

The decision to buy CHMMF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CHMMF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CHMMF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CHMMF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if CHMMF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is CHMMF's P/E ratio?

P/E ratio data for CHMMF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is CHMMF's market cap?

CHMMF (Chimeric Therapeutics Limited) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is CHMMF's price to book ratio?

Price-to-book ratio for CHMMF is available on our dashboard along with other valuation metrics.

Does CHMMF pay dividends?

CHMMF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is CHMMF's dividend yield?

CHMMF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is CHMMF stock a good long-term investment?

CHMMF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CHMMF's revenue growth rate?

Revenue growth data for CHMMF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CHMMF are available on our dashboard with complete income statement analysis.

What are the risks of investing in CHMMF?

Key risks for CHMMF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CHMMF compare to its competitors?

Compare CHMMF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CHMMF's performance and positioning.

What is CHMMF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for CHMMF with bull, base, and bear case scenarios.

What do analysts say about CHMMF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CHMMF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CHMMF's next earnings report?

CHMMF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CHMMF - Chimeric Therapeutics Limited

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Chimeric Therapeutics Limited

Chimeric Therapeutics Limited (CHMMF) common stock

Price Chart

Loading chart...

CHMMF Key Statistics

Market Cap

$5.18M

How CHMMF Compares to Peers

CHMMF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CHMMF(This stock)	$5.18M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 18, 2026 at 4:47 PM EDT

Ready to invest in CHMMF?

Commission-free trading available. Affiliate links.

Upcoming Events for CHMMF

Dashboard

Enter a ticker to analyze